
We are the Azoitei lab @TheDHVI ! Working on next generation vaccines against influenza, HIV and coronaviruses.
Durham, NC
Joined October 2021
- Tweets165
- Following106
- Followers127
- Likes234
Happy holidays from the Azoitei Lab!!!
We felt festive and Caitlin (our resident figure maker) was tasked with creating some science filled holiday artwork.
Hope you all have a wonderful rest of the year! Cheers to friends and family 🎉
Here’s to 2026!! 🥂✨
Going viral... in a good way 😋
corporate.dukehealth.org/new…
abc11.com/post/duke-research…
Mihai Azoitei retweeted
This week's issue of #ScienceTranslationalMedicine has arrived!
Personalized electric stimulation shows promise in two patients with spinal cord injuries, a study shows that Staph bacteria rapidly evolve resistance to new antibiotic candidates, and more. scim.ag/4j0qH4i
An immunogen to activate diverse HIV bnAb precursors & start their maturation process through the acquisition of key functional mutations. A collab w/ @PriyamvadaA_Lab, Kevin Saunders lab, Kevin Wiehe, @lab_haynes, Derek Cain, and many others at @TheDHVI and @DukeU @DukeMedSchool
Our latest paper was just published in @ScienceTM and highlighted on the cover! 🔬🧪🧬
Congrats to first authors Olivia Swanson (@swansolive) and Ellie Zhang 🥳🥳
Read our paper --> [duke.is/Swan]
Annual @TheDHVI Holiday Party was a blast!!! 🎄🎁🎉🎉🎉
Shout out to Irina for winning some awesome basketball tickets!!
Mihai Azoitei retweeted
In 2003, this year’s chemistry laureate David Baker succeeded in designing a new protein that was unlike any other protein. This was the first step in something that can only be described as an extraordinary development. A few of the many spectacular proteins created in Baker’s laboratory using his computer software Rosetta can be seen in the picture.
He also released the code for Rosetta, so a global research community has continued to develop the software, finding new areas of application.
Baker’s research group has produced one imaginative protein creation after another, including proteins that can be used as pharmaceuticals, vaccines, nanomaterials and tiny sensors.
Mihai Azoitei retweeted
BREAKING NEWS
The Royal Swedish Academy of Sciences has decided to award the 2024 #NobelPrize in Chemistry with one half to David Baker “for computational protein design” and the other half jointly to Demis Hassabis and John M. Jumper “for protein structure prediction.”
Many thanks and well wishes as we send off Brenda to her new job at the CDC in SC!! 🧬🥼
It’s been an incredible 4 years with you and our lab will never be the same without you.
We all hope you come visit sometime soon! @IKapingidza
Mihai Azoitei retweeted
The HVTN 133 trial demonstrated the first success of vaccine induction of polyclonal heterologous HIV-1-neutralizing antibodies that target gp41 MPER @CellCellPress @TheDHVI @wbw0625 Alam, Ofek, Baden, Walsh
cell.com/cell/fulltext/S0092…
Mihai Azoitei retweeted
We're advancing a new global agreement signed by 100+ leading scientists to ensure AI technologies for protein design are developed responsibly. This field can deliver medicines, vaccines, and other innovations that benefit all.
ipd.uw.edu/2024/03/our-commi…
responsiblebiodesign.ai/
Mihai Azoitei retweeted
Happy International Women's Day!
#Duke100
Also published a paper in Plos Pathogens, presented at many conferences across North America and watched many of our lovely undergrads graduate from Duke!!
We are so proud to have accomplished so many things listed here and more.
Happy holidays & Happy new year!!! 🎊🎆
Annual Azoitei lab holiday party!! Cookies & crafts make for great bonding times 🥳🥳
We’re winding down from a great year. Added 2 new post docs & research techs to the lab and published a paper in Nature Comms!!
Can’t wait to see what the new year brings. Bring it on 2024!!
We are featured in @NatureComms Editors' Highlight page for Biotechnology and methods.
Follow the link below to find our article!!
nature.com/collections/idhhg…
Mihai Azoitei retweeted
Replying to @AzoiteiLab
@AzoiteiLab @TheDHVI @DukeU computationally engineer and experimentally validate immunogens to elicit antibodies against spike regions conserved across diverse coronaviruses.
#panBCoVvaccine #immunogendesign #BiotechNatureComms
nature.com/articles/s41467-0…
























